Framatome and KHNP explore medical isotope production at South Korea

Framatome and KHNP explore medical isotope production at South Korea

Energy Daily

Published

Paris, France (SPX) Apr 19, 2024

Framatome and Korea Hydro and Nuclear Power (KHNP) have entered a Memorandum of Understanding (MoU) to explore the production of non-carrier added Lutetium-177, a critical medical isotope used in cancer treatments, at the Wolsong nuclear power plant in South Korea. The companies will conduct a joint technical assessment using Framatome's proprietary isotope production technology, already o

Full Article